NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE

The article describes advantages of new combined drug Foster — formoterol (6 ?g) and beclometasone) (100 ?g) in treatment of patients with bronchial asthma. It was marked that the drug is based on original delivery technology «Modulite» allowing creation an aerosol with extra fine-dispersed particle...

Full description

Bibliographic Details
Main Author: O.I. Simonova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2010-05-01
Series:Вопросы современной педиатрии
Online Access:https://vsp.spr-journal.ru/jour/article/view/905
_version_ 1826561970996772864
author O.I. Simonova
author_facet O.I. Simonova
author_sort O.I. Simonova
collection DOAJ
description The article describes advantages of new combined drug Foster — formoterol (6 ?g) and beclometasone) (100 ?g) in treatment of patients with bronchial asthma. It was marked that the drug is based on original delivery technology «Modulite» allowing creation an aerosol with extra fine-dispersed particles. Due to this technology medication passes into airways deeper and evenly, resulting in decrease of dose of medication, necessary for achievement of clinical effect and significantly lessen the risk of adverse effects.Key words: children, bronchial asthma, fixed combination, formoterol, beclometasone.(Voprosy sovremennoi pediatrii — Current Pediatrics. – 2010;9(3):136-139)
first_indexed 2024-03-12T03:43:19Z
format Article
id doaj.art-2c090578f36746ac99b7af8a58a9affd
institution Directory Open Access Journal
issn 1682-5527
1682-5535
language English
last_indexed 2025-03-14T09:40:39Z
publishDate 2010-05-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj.art-2c090578f36746ac99b7af8a58a9affd2025-03-02T11:34:10Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352010-05-0193136139906NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONEO.I. Simonova0Scientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowThe article describes advantages of new combined drug Foster — formoterol (6 ?g) and beclometasone) (100 ?g) in treatment of patients with bronchial asthma. It was marked that the drug is based on original delivery technology «Modulite» allowing creation an aerosol with extra fine-dispersed particles. Due to this technology medication passes into airways deeper and evenly, resulting in decrease of dose of medication, necessary for achievement of clinical effect and significantly lessen the risk of adverse effects.Key words: children, bronchial asthma, fixed combination, formoterol, beclometasone.(Voprosy sovremennoi pediatrii — Current Pediatrics. – 2010;9(3):136-139)https://vsp.spr-journal.ru/jour/article/view/905
spellingShingle O.I. Simonova
NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE
Вопросы современной педиатрии
title NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE
title_full NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE
title_fullStr NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE
title_full_unstemmed NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE
title_short NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE
title_sort new medicinal form in treatment of bronchial asthma fixed combination of formoterol and beclometasone
url https://vsp.spr-journal.ru/jour/article/view/905
work_keys_str_mv AT oisimonova newmedicinalformintreatmentofbronchialasthmafixedcombinationofformoterolandbeclometasone